Mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies, shows new research. Findings published in the American College of Rheumatology (ACR) journal iArthritis (and) Rheumatism/i, soon to be called Arthritis (and) Rheumatology, indicate the higher mortality rates persisted after adjusting for age, positive rheumatoid factor, positive antinuclear antibodies (ANA) and disease ...Monday, 23 December 2013
Higher Mortality in Postmenopausal Women: Research
Mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies, shows new research. Findings published in the American College of Rheumatology (ACR) journal iArthritis (and) Rheumatism/i, soon to be called Arthritis (and) Rheumatology, indicate the higher mortality rates persisted after adjusting for age, positive rheumatoid factor, positive antinuclear antibodies (ANA) and disease ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment